These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12924645)

  • 41. Tumour-related neoangiogenesis: functional dynamic perfusion computed tomography for diagnosis and treatment efficacy assessment in hepatocellular carcinoma.
    Ippolito D; Fior D; Franzesi CT; Capraro C; Casiraghi A; Leni D; Vacirca F; Corso R; Sironi S
    Dig Liver Dis; 2014 Oct; 46(10):916-22. PubMed ID: 25023006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
    Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
    Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT.
    Kanata N; Yoshikawa T; Ohno Y; Kanda T; Uchida K; Izaki K; Fukumoto T; Ku Y; Itoh T; Kitajima K; Takahashi S; Sugimura K
    Magn Reson Imaging; 2013 Jan; 31(1):17-22. PubMed ID: 22898685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase-contrast CT: Qualitative and Quantitative Evaluation of Capillarized Sinusoids and Trabecular Structure in Human Hepatocellular Carcinoma Tissues.
    Jian J; Zhang W; Yang H; Zhao X; Xuan R; Li D; Hu C
    Acad Radiol; 2017 Jan; 24(1):67-75. PubMed ID: 27818006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small hepatocellular carcinomas undetected on two-phased incremental computed tomography. Angiographic and clinicopathologic findings.
    Honda H; Kaneko K; Maeda T; Kuroiwa T; Fukuya T; Yoshimitsu K; Irie H; Aibe H; Takenaka K; Tsuneyoshi M
    Invest Radiol; 1995 Aug; 30(8):458-65. PubMed ID: 8557511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of tumor hemodynamics in small hepatocellular carcinoma: comparison of Doppler ultrasonography, angiography-assisted computed tomography, and pathological findings.
    Kumada T; Nakano S; Toyoda H; Hayashi K; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamamoto A; Takeshima K; Hibi T; Yabashi T; Noda T; Sassa T; Furukawa M; Ogawa S
    Liver Int; 2004 Oct; 24(5):425-31. PubMed ID: 15482338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intranodular blood supply correlates well with biological malignancy grade determined by tumor growth rate in pathologically proven hepatocellular carcinoma.
    Kudo M; Tochio H
    Oncology; 2008; 75 Suppl 1():55-64. PubMed ID: 19092273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Radiological Differentiation of Hypervascular Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma with a Focus on the CT Value on Multi-phase Enhanced CT.
    Sano S; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Aramaki T; Nakanuma Y; Uesaka K
    Anticancer Res; 2018 Sep; 38(9):5505-5512. PubMed ID: 30194209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Lipiodol-CT for the detection of small hypovascular HCC].
    Ibukuro K; Fukuda H; Mori K; Sato S; Inoue Y; Fujino H; Uta Y; Tagawa H; Unuma N; Shichijo Y
    Rinsho Hoshasen; 1990 Sep; 35(9):1011-4. PubMed ID: 2172600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of 128 slice 4D CT whole liver perfusion imaging in hepatic tumor.
    Guo M; Yu Y
    Cell Biochem Biophys; 2014 Sep; 70(1):173-8. PubMed ID: 24691926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Computed tomography -- Xenon CT in the diagnosis of liver tumors].
    Rofo; 2005 Jan; 177(1):9. PubMed ID: 15657842
    [No Abstract]   [Full Text] [Related]  

  • 55. Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma.
    Murakami T; Hori M; Kim T; Kawata S; Abe H; Nakamura H
    Intervirology; 2004; 47(3-5):209-26. PubMed ID: 15383731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT.
    Goshima S; Kanematsu M; Noda Y; Kawai N; Kawada H; Ono H; Bae KT
    AJR Am J Roentgenol; 2016 Mar; 206(3):518-25. PubMed ID: 26901007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Xenon-enhanced CT].
    Dono K; Shimizu J; Hayashi S; Monden M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():284-7. PubMed ID: 11761957
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical Indication for Computed Tomography During Hepatic Arteriography (CTHA) in Addition to Dynamic CT Studies to Identify Hypervascularity of Hepatocellular Carcinoma.
    Fuji T; Nakamura Y; Fukumoto W; Kajiwara K; Chosa K; Tani C; Matsubara Y; Terada H; Honda Y; Arihiro K; Iida M; Baba Y; Awai K
    Cardiovasc Intervent Radiol; 2018 Apr; 41(4):618-627. PubMed ID: 29101449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative characterization of hepatocellular carcinoma and metastatic liver tumor by CT perfusion.
    Hayano K; Desai GS; Kambadakone AR; Fuentes JM; Tanabe KK; Sahani DV
    Cancer Imaging; 2013 Dec; 13(4):512-9. PubMed ID: 24334461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.